Announcements
Trials
Browse
Landscape
Clinical Trials
5 trials
Recent
Start date
Enrollment
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
pembrolizumab
×
Lymphoid
×
Clear all
Filters
3
NCT02684292
2026-02-18
MK-3475-204
Merck Sharp & Dohme LLC
Phase 3
Completed
304 enrolled
2 FDA
NCT03598608
2026-02-05
MK-4280-003
Merck Sharp & Dohme LLC
Phase 1/2
Completed
137 enrolled
NCT05508867
2026-01-20
MK-4280A-008
Merck Sharp & Dohme LLC
Phase 2
Completed
203 enrolled
NCT03010176
2025-10-29
MK-1454-001
Merck Sharp & Dohme LLC
Phase 1
Completed
156 enrolled
20 charts
NCT04317066
2025-04-06
KEYNOTE-A33
Merck Sharp & Dohme LLC
Phase 1
Completed
7 enrolled
13 charts